TrialFrontiers in immunology2020

Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results.

Rita Fazzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.